The Technical Analyst
Select Language :
Agenus Inc [AGEN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Agenus Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

Agenus Inc is listed at the  Exchange

4.24% $0.580

America/New_York / 28 mar 2024 @ 16:00


FUNDAMENTALS
MarketCap: 242.97 mill
EPS: -0.690
P/E: -0.840
Earnings Date: May 07, 2024
SharesOutstanding: 418.92 mill
Avg Daily Volume: 10.35 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.840 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.14x
Company: PE -0.840 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.498 - 0.662

( +/- 14.14%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-22 Armen Garo H Buy 27 163 Common Stock
2024-03-08 Armen Garo H Buy 22 136 Common Stock
2024-02-23 Armen Garo H Buy 21 815 Common Stock
2024-02-15 Armen Garo H Buy 500 000 Common Stock
2024-02-09 Armen Garo H Buy 19 778 Common Stock
INSIDER POWER
100.00
Last 98 transactions
Buy: 11 767 042 | Sell: 367 647

Forecast: 16:00 - $0.573

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.573
Forecast 2: 16:00 - $0.573
Forecast 3: 16:00 - $0.573
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.580 (4.24% )
Volume 5.15 mill
Avg. Vol. 10.35 mill
% of Avg. Vol 49.82 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Agenus Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Agenus Inc

RSI

Intraday RSI14 chart for Agenus Inc

Last 10 Buy & Sell Signals For AGEN

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$0.702N/AActive
Profile picture for
            Agenus Inc

AGEN

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 monospecific antibody that is in Phase 1 clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1777, an anti-TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody. In addition, the company develops INCAGN1876, an anti-GITR monospecific antibody; INCAGN1949, an anti-OX40 monospecific antibody; INCAGN2390, an anti-TIM-3 monospecific antibody; INCAGN2385, an anti-LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4; AGENT 797, an iNKT cells that is in Phase 1 clinical trial for solid tumors, multiple myeloma, and viral ARDS, as well as in clinical stage to treat hematological malignancies and multiple myeloma/B cells; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. Agenus Inc. operates under ASV, Agenus, AutoSynVax, EVAMPLIX, MiNK, PSV, PhosPhoSynVax, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Incyte Corporation, Merck Sharpe & Dohme, Recepta Biopharma SA, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Last 10 Buy Signals

Date Signal @
YF-DAIUSDMar 29 - 02:0548.11
SETHUSDMar 29 - 02:003 555.60
SNBNBUSDMar 29 - 01:51607.75
IONUSDMar 29 - 02:00451.01
^N225Mar 29 - 02:00PTS40 369
DAOUSDMar 29 - 01:54$1.742
BONDUSDMar 29 - 01:534.97
NOSUSDMar 29 - 01:494.05
FOLDUSDMar 29 - 01:4824.92
PENDLEUSDMar 29 - 01:434.34

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.